Basic info
Industry
biotechnology
Sectors
Chronic Hepatitis B
Real-world data
Regulatory Grade Data
Patient data
Immune-Mediated Inflammatory Skin Conditions
Asthma
Research Registry
Value Evidence
Data linking
Health Care
Health Evidence Solutions
Medical
Primary Biliary Cholangitis
Inflammatory Bowel Disease
Nonalcoholic Steatohepatitis
Real-world evidence
Hepatocellular Carcinoma
Date founded
2015
Funding rounds raised
Total raised
$638K
from 2 investors over 2 rounds
T
TARGET PharmaSolutions raised undisclosed on December 1, 2016
Investors: VentureSouth
T
TARGET PharmaSolutions raised $638K on January 20, 2016
Investors: VentureSouth